J. Hindson Benjamin's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 7,486 Class A Common Stock done at an average price of $13.8 . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 22 Aug 2025 | 7,486 | 440,888 (2%) | 0% | 13.8 | 103,209 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 8.30 per share. | 22 May 2025 | 7,485 | 448,374 (2%) | 0% | 8.3 | 62,120 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 120,535 | 455,859 (2%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 24 Feb 2025 | 4,573 | 335,324 (1%) | 0% | 11.1 | 50,603 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 22 Nov 2024 | 5,807 | 339,897 (1%) | 0% | 13.7 | 79,485 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 22 Aug 2024 | 4,351 | 345,704 (1%) | 0% | 22.5 | 98,027 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 22 May 2024 | 4,087 | 350,055 (1%) | 0% | 24.3 | 99,329 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 71,083 | 354,142 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | J. Hindson Benjamin | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 46.34 per share. | 22 Feb 2024 | 2,613 | 283,059 (1%) | 0% | 46.3 | 121,098 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Hindson Benjamin J. | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 8,334 | 14,978 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 28 Dec 2023 | 8,334 | 285,672 (1%) | 0% | 11.5 | 95,674 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 3,449 | 280,787 (1%) | 0% | 45.8 | 157,899 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 6,970 | 23,312 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Aug 2023 | 6,970 | 291,206 (1%) | 0% | 11.5 | 80,016 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 62.36 per share. | 01 Aug 2023 | 5,243 | 284,236 (1%) | 0% | 62.4 | 326,933 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 61.77 per share. | 01 Aug 2023 | 1,727 | 289,479 (1%) | 0% | 61.8 | 106,679 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 19 Jul 2023 | 13,940 | 284,236 (1%) | 0% | 60.0 | 836,834 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 19 Jul 2023 | 12,972 | 297,208 (1%) | 0% | 5.0 | 65,379 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 12,972 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 968 | 30,282 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 19 Jul 2023 | 968 | 298,176 (1%) | 0% | 11.5 | 11,113 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 791 | 284,236 (1%) | 0% | 55.1 | 43,553 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 735 | 285,027 (1%) | 0% | 55.1 | 40,471 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 619 | 285,762 (1%) | 0% | 55.1 | 34,082 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 23 May 2023 | 243 | 286,381 (1%) | 0% | 55.1 | 13,379 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 36,387 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 286,624 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 18,194 | 18,194 | - | - | Performance- based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 47.75 per share. | 22 Feb 2023 | 1,742 | 250,237 (1%) | 0% | 47.8 | 83,186 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 1,087 | 217,713 (1%) | 0% | 34.1 | 37,032 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 915 | 218,800 (1%) | 0% | 34.1 | 31,172 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 359 | 219,715 (1%) | 0% | 34.1 | 12,230 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 67,655 | 67,655 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 67,655 | 67,655 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 33,828 | 220,074 (1%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Aug 2022 | 1,292 | 186,246 (0%) | 0% | 35.2 | 45,467 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 48.76 per share. | 23 May 2022 | 1,264 | 187,538 (0%) | 0% | 48.8 | 61,637 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 71,189 | 71,189 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 28,476 | 188,802 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 267,000 | 2,733,000 | - | - | Class B Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 133,500 | 133,500 | - | - | Class B Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Feb 2022 | 133,500 | 133,500 | - | - | Class B Common Stock | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 78.59 per share. | 22 Feb 2022 | 360 | 160,326 (0%) | 0% | 78.6 | 28,294 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.58 per share. | 03 Jan 2022 | 39,582 | 202,352 (0%) | 0% | 74.6 | 2,952,026 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 39,582 | 93,630 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 146.29 per share. | 03 Jan 2022 | 17,396 | 166,192 (0%) | 0% | 146.3 | 2,544,927 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 145.43 per share. | 03 Jan 2022 | 16,464 | 183,588 (0%) | 0% | 145.4 | 2,394,422 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 147.34 per share. | 03 Jan 2022 | 2,906 | 163,286 (0%) | 0% | 147.3 | 428,160 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 144.56 per share. | 03 Jan 2022 | 2,300 | 200,052 (0%) | 0% | 144.6 | 332,478 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,084 | 31,250 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 03 Jan 2022 | 2,084 | 162,770 (0%) | 0% | 11.5 | 23,924 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.44 per share. | 03 Jan 2022 | 2,000 | 161,286 (0%) | 0% | 148.4 | 296,871 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 149.24 per share. | 03 Jan 2022 | 600 | 160,686 (0%) | 0% | 149.2 | 89,546 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 59,968 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Dec 2021 | 59,968 | 160,686 (0%) | 0% | 1.2 | 71,962 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 53,952 | 0 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.07 per share. | 28 Dec 2021 | 53,952 | 100,718 (0%) | 0% | 1.1 | 57,729 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 35,232 | 33,334 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Dec 2021 | 35,232 | 85,644 (0%) | 0% | 11.5 | 404,463 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 147.65 per share. | 01 Dec 2021 | 13,561 | 64,102 (0%) | 0% | 147.7 | 2,002,305 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.42 per share. | 01 Dec 2021 | 7,571 | 56,531 (0%) | 0% | 148.4 | 1,123,696 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 145.66 per share. | 01 Dec 2021 | 5,400 | 83,032 (0%) | 0% | 145.7 | 786,541 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 146.53 per share. | 01 Dec 2021 | 5,369 | 77,663 (0%) | 0% | 146.5 | 786,700 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 149.46 per share. | 01 Dec 2021 | 4,849 | 51,682 (0%) | 0% | 149.5 | 724,718 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 3,646 | 47,238 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Dec 2021 | 3,646 | 50,412 (0%) | 0% | 5.0 | 18,376 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 2,788 | 133,212 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.58 per share. | 01 Dec 2021 | 2,788 | 88,432 (0%) | 0% | 74.6 | 207,929 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 151.46 per share. | 01 Dec 2021 | 2,100 | 47,766 (0%) | 0% | 151.5 | 318,061 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 150.66 per share. | 01 Dec 2021 | 1,816 | 49,866 (0%) | 0% | 150.7 | 273,602 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 153.91 per share. | 01 Dec 2021 | 700 | 46,966 (0%) | 0% | 153.9 | 107,740 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 155.55 per share. | 01 Dec 2021 | 200 | 46,766 (0%) | 0% | 155.6 | 31,110 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 152.25 per share. | 01 Dec 2021 | 100 | 47,666 (0%) | 0% | 152.3 | 15,225 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 22 Nov 2021 | 351 | 46,766 (0%) | 0% | 148.4 | 52,082 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 31,434 | 68,566 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 01 Nov 2021 | 31,434 | 88,783 (0%) | 0% | 11.5 | 360,862 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 163.87 per share. | 01 Nov 2021 | 24,125 | 50,229 (0%) | 0% | 163.9 | 3,953,296 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 163.15 per share. | 01 Nov 2021 | 11,829 | 74,354 (0%) | 0% | 163.2 | 1,929,950 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 10,232 | 50,884 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Nov 2021 | 10,232 | 57,349 (0%) | 0% | 5.0 | 51,569 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 164.75 per share. | 01 Nov 2021 | 3,112 | 47,117 (0%) | 0% | 164.8 | 512,706 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 162.06 per share. | 01 Nov 2021 | 1,500 | 86,183 (0%) | 0% | 162.1 | 243,091 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 160.50 per share. | 01 Nov 2021 | 1,100 | 87,683 (0%) | 0% | 160.5 | 176,554 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 01 Oct 2021 | 41,666 | 88,783 (0%) | 0% | 5.0 | 209,997 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 41,666 | 61,116 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 143.97 per share. | 01 Oct 2021 | 21,469 | 49,617 (0%) | 0% | 144.0 | 3,090,892 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 143.13 per share. | 01 Oct 2021 | 13,297 | 71,086 (0%) | 0% | 143.1 | 1,903,154 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 142.16 per share. | 01 Oct 2021 | 4,400 | 84,383 (0%) | 0% | 142.2 | 625,491 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 144.77 per share. | 01 Oct 2021 | 2,500 | 47,117 (0%) | 0% | 144.8 | 361,923 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 161.85 per share. | 23 Aug 2021 | 337 | 47,117 (0%) | 0% | 161.8 | 54,543 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 02 Aug 2021 | 30,552 | 89,120 (0%) | 0% | 5.0 | 153,982 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 30,552 | 144,448 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 11,114 | 59,968 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 02 Aug 2021 | 11,114 | 58,568 (0%) | 0% | 1.2 | 13,337 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 180.13 per share. | 02 Aug 2021 | 10,713 | 64,454 (0%) | 0% | 180.1 | 1,929,777 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 181.13 per share. | 02 Aug 2021 | 8,800 | 55,654 (0%) | 0% | 181.1 | 1,593,961 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 179.08 per share. | 02 Aug 2021 | 8,050 | 75,167 (0%) | 0% | 179.1 | 1,441,596 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 178.25 per share. | 02 Aug 2021 | 5,903 | 83,217 (0%) | 0% | 178.2 | 1,052,191 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 181.98 per share. | 02 Aug 2021 | 5,200 | 50,454 (0%) | 0% | 182.0 | 946,300 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 183.02 per share. | 02 Aug 2021 | 1,800 | 48,654 (0%) | 0% | 183.0 | 329,441 | Class A Common Stock |
| 10x Genomics Inc Ordinary | Benjamin J. Hindson | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 184.02 per share. | 02 Aug 2021 | 800 | 47,854 (0%) | 0% | 184.0 | 147,220 | Class A Common Stock |